Download PDF
1 / Pages

Other users also viewed these articles

Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project Santos Castañeda; Carlos González; Virginia Villaverde; Cristina Lajas Petisco; María Carmen Castro; Fernando Jirout; Juan Carlos Obaya; Juan Carlos Hermosa; Carmen Suárez; Silvia García; María Rodero; Leticia León; Amparo López Esteban; Milena Gobbo; Laly Alcaide; Juan Carlos Torre-Alonso;
Reumatol Clin. 2022;18:114-23
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;
Reumatol Clin. 2020;16P1:345-52
Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5